beta

SYBX

Synlogic Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

at synlogic, we are dedicated to bringing innovative medicines to patients by driving the convergence of two revolutionary fields: synthetic biology and the microbiome. using our synthetic biotics platform, we are engineering probiotic bacteria to perform specific therapeutic functions with established links to disease. we can deliver these synthetic biotics™ orally, where they act from the gut microbiome to correct missing or dysfunctional metabolic activities throughout the body. we also aim to deliver synthetic biotics at the site of disease in cases where local activity is critical, as in stimulation of immune effectors to combat certain tumors. we can rapidly translate this groundbreaking science and technology into medicines that have the potential to change the lives of patients. our lead programs target patients with rare genetic metabolic diseases, including urea cycle disorders (ucd) and phenylketonuria (pku). we are also hard at work on synthetic biotics™ to address more pre

Market Cap: 17 Million

Primary Exchange: NASDAQ

Website: https://www.synlogictx.com/

Shares Outstanding: 9.19 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.5662113102133581

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 1515 trading days

From: 2015-12-17 To: 2024-03-07

Lowest Point:

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-12 08:39:07:000

Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N… read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-12 08:39:07:000

Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N… read more...

SYBX, MAT among premarket gainers

via: SeekingAlpha at 2019-06-12 05:16:31:000

Synlogic (NASDAQ: SYBX ) +26% as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more … read more...

SYBX, MAT among premarket gainers

via: SeekingAlpha at 2019-06-12 05:16:31:000

Synlogic (NASDAQ: SYBX ) +26% as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more … read more...

Ginkgo Bioworks to invest $80M in Synlogic at a premium

via: SeekingAlpha at 2019-06-12 02:49:08:000

Synlogic (NASDAQ: SYBX ) and Ginkgo Bioworks announce a platform collaboration to accelerate expansion and development of Synlogic's pipeline of Synthetic Bioticmedicines using Ginkgo's cell programming platform for building and testing microbial strains to accelerate progression of early pr… read more...

Ginkgo Bioworks to invest $80M in Synlogic at a premium

via: SeekingAlpha at 2019-06-12 02:49:08:000

Synlogic (NASDAQ: SYBX ) and Ginkgo Bioworks announce a platform collaboration to accelerate expansion and development of Synlogic's pipeline of Synthetic Bioticmedicines using Ginkgo's cell programming platform for building and testing microbial strains to accelerate progression of early pr… read more...

Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic(TM) Medicines

via: Business Wire at 2019-06-12 02:30:00:000

Fuels development of Synlogics growing pipeline of novel living medicines with technology access and $80.0 million equity investment at a premium Applies Ginkgos high-throughput synthetic biology platform services to human therapeutics &#x2013… read more...

Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic(TM) Medicines

via: Business Wire at 2019-06-12 02:30:00:000

Fuels development of Synlogics growing pipeline of novel living medicines with technology access and $80.0 million equity investment at a premium Applies Ginkgos high-throughput synthetic biology platform services to human therapeutics &#x2013… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-08-28 7.0 1.0 7.0
Data provided by IEX Cloud